SCHEMBL12419575

SCHEMBL12419575

OB(O)c1ccc(-c2nnc(-c3cccc4c3OCO4)o2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 12/20 0.44
▸ NPC1 O15118 11/20 0.44
▸ RAB9A P51151 11/20 0.44
▸ KDM4E B2RXH2 8/20 0.44
▸ SMN1; SMN2 Q16637 8/20 0.44
▸ MAPT P10636 5/20 0.44
▸ NFKB1 P19838 2/20 0.44
▸ NFKB2 Q00653 2/20 0.44
▸ RELA Q04206 2/20 0.44
▸ CHEK1 O14757 1/20 0.38
▸ CHEK2 O96017 1/20 0.38
▸ TSHR P16473 8/20 0.37
▸ HPGD P15428 7/20 0.37
▸ HSD17B10 Q99714 6/20 0.37
▸ TP53 P04637 3/20 0.37
▸ GAA P10253 3/20 0.37
▸ ALOX15 P16050 3/20 0.37
▸ POLB P06746 2/20 0.37
▸ PKM P14618 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12419558 0.90 STIM1 (0.39) ALDH1A1NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL12419567 0.79 PARP1 (0.37) ALDH1A1NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL12419612 0.79 CHEK1 (0.37) ALDH1A1RAB9AKDM4ESMN1; SMN2CHEK1
SCHEMBL12419740 0.78 ALDH1A1 (0.37) ALDH1A1NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL12419565 0.77 NPC1 (0.67) ALDH1A1NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL3716830 0.74 ALDH1A1 (0.39) ALDH1A1NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL12419559 0.73 RAB9A (0.53) ALDH1A1NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL2816834 0.72 NPC1 (0.65) ALDH1A1NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL16488121 0.72 ATR (0.48) ALDH1A1NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL12419574 0.71 NPC1 (0.52) ALDH1A1NPC1RAB9AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 — — US disclosed
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 — — US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 — — US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 — — US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 — — US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 — — US disclosed
WO-2009126691-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC (US) 2009-10-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 ALDH1A1 354/4885NPC1 472/4885RAB9A 1820/4885
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 ALDH1A1 354/4885NPC1 472/4885RAB9A 1820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback